{
    "Trade/Device Name(s)": [
        "Virtuoso\u2122 System for IHC p53 (DO-7)",
        "Virtuoso\u2122M System for IHC p53 (DO-7)"
    ],
    "Submitter Information": "Ventana Digital Pathology",
    "510(k) Number": "K121350",
    "Predicate Device Reference 510(k) Number(s)": [
        "K111872"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NOT",
        "NQN",
        "OEO"
    ],
    "Summary Letter Date": "May 3, 2012",
    "Summary Letter Received Date": "May 4, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.1860"
    ],
    "Regulation Name(s)": [
        "Immunohistochemistry reagents and kits"
    ],
    "Analyte Class(es)": [
        "anatomic pathology",
        "cancer molecular"
    ],
    "Analyte(s)": [
        "p53 protein"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded tissue",
        "Histologic section",
        "Breast cancer specimen"
    ],
    "Specimen Container(s)": [
        "Glass slide"
    ],
    "Instrument(s)/Platform(s)": [
        "Ventana iScan slide scanner",
        "Benchmark ULTRA stainer",
        "Benchmark XT stainer",
        "Computer",
        "Monitor",
        "Keyboard",
        "Mouse"
    ],
    "Method(s)/Technology(ies)": [
        "Digital pathology",
        "Image analysis",
        "Immunohistochemistry"
    ],
    "Methodologies": [
        "Computer-assisted quantitative scoring",
        "Digital read",
        "Image analysis"
    ],
    "Submission Type(s)": [
        "System",
        "Accessory",
        "Software",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for Virtuoso System for IHC p53 (DO-7), a digital pathology and image analysis system for semi-quantitative measurement of p53 protein in breast cancer tissue.",
    "Indications for Use Summary": "Aids pathologists in display, detection, counting, review and classification of immunohistochemically stained breast cancer tissues and cells; assists in detection and semi-quantitative measurement of p53 (DO-7) protein, used as accessory with CONFIRM anti-p53 (DO-7) assay, to assess p53 status in breast cancer patients.",
    "fda_folder": "Hematology"
}